Publication & Citation Trends
Most Cited Works
Publications
84 total
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer PDF
Cited by 80
OpenAlex
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance PDF
Cited by 84
OpenAlex
Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer PDF
Cited by 103
OpenAlex
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
Cited by 413
OpenAlex
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer PDF
Cited by 283
OpenAlex
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins PDF
Cited by 96
OpenAlex
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer PDF
Cited by 96
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(30)
PI3K/AKT/mTOR signaling in cancer
(14)
Liver physiology and pathology
(12)
Cancer Genomics and Diagnostics
(11)
Hippo pathway signaling and YAP/TAZ
(8)
Frequent Co-Authors
Affiliations
San Francisco VA Medical Center
City College of San Francisco
University of Massachusetts Chan Medical School
University of California, San Francisco
JPS Health Network